The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study

Sponsor
Michel Adamina, MD (Other)
Overall Status
Suspended
CT.gov ID
NCT04985981
Collaborator
Cantonal Hospital of St. Gallen (Other), University Hospital, Geneva (Other), Clarunis - Universitäres Bauchzentrum Basel (Other), University Hospital, Basel, Switzerland (Other), University of Zurich (Other)
11,000
2
21
5500
262

Study Details

Study Description

Brief Summary

The Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study aims to establish a machine-learning-based application that allows for accurate preoperative prediction of patients at risk for anastomotic insufficiency after colon and colorectal surgery.

Detailed Description

Anastomotic insufficiency leads to clinical strains for patients, and significantly increases morbidity and mortality. On average, hospital stay is extended by 12 days while healthcare-related expenses are increased by 30,000 USD when patients suffer from an anastomotic leak. In experienced centers, the approximated incidence of anastomotic insufficiency is 3,3% for colon and 8.6% for colorectal procedures. Multiple subgroups of patients with increased risk for anastomotic leaks have been described in previous publications. Meticulous preoperative recognition of patients with increased risk for anastomotic insufficiency is clinically beneficial, as it would permit improved ressource preparation, enhanced patient education and superior surgical decision-making. However, it is often difficult for clinicians to balance the plethora of crucial risk factors for anastomotic leaks for a single patient. Machine learning methods have been exceptionally effective at incorporating various clinical variables into one unified risk prediction model. To the authors' best knowledge, there does not yet exist a credible prediction model or a conclusive prediction score for anastomotic insufficiency after colon and colorectal anastomosis. The aim of the Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study is to establish and externally validate an efficient machine-learning-based prediction tool based on multicenter data from a range of international centers.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
11000 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study: Development and External Validation of an International, Multicenter Machine Learning Algorithm for Prediction of Anastomotic Insufficiency After Colonic or Colorectal Anastomosis
Actual Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Occurrence of Anastomotic leak [5 years]

    Occurrence of anastomotic insufficiency/leak is defined as any clinical signs of leakage, confirmed by radiological examination, endoscopy, clinical examination of the anastomosis, or upon reoperation.

Secondary Outcome Measures

  1. Occurrence of Death [90 days]

  2. Time to diagnosis of anastomotic leak [90 days]

    Time to diagnosis of a leakage will be calculated as days between the index operation and diagnosis of the leakage by imaging with extraluminal contrast, endoscopy, re-operation, or when fecal containing fluid is objectified in a drainage.

Other Outcome Measures

  1. Disease-free survival (months) [5 years]

  2. Overall survival (months) [5 years]

  3. Adjuvant/additive immunochemotherapy (yes/no) [5 years]

    Did the patient receive adjuvant/additive immunochemotherapy after surgery? (yes/no)

  4. Adjuvant/additive radiotherapy (yes/no) [5 years]

    Did the patient receive adjuvant/additive radiotherapy after surgery? (yes/no)

  5. Additive curative surgery (no/yes: liver; lung; locoragional relapse) [5 years]

    Did the patient receive additive curative surgery after the initial intervention? (no/yes: liver; lung; locoragional relapse)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease
Exclusion Criteria:
  • age < 18

  • recurrent colorectal cancer

  • peritoneal carcinomatosis or unresectable metastatic disease at time of bowel resection

  • informed consent not obtainable

  • follow-up < 6 weeks after surgery

  • no reversal of and ostomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland Allschwil Basel Switzerland 4123
2 Kantonsspital Winterthur Winterthur Zürich Switzerland 8401

Sponsors and Collaborators

  • Michel Adamina, MD
  • Cantonal Hospital of St. Gallen
  • University Hospital, Geneva
  • Clarunis - Universitäres Bauchzentrum Basel
  • University Hospital, Basel, Switzerland
  • University of Zurich

Investigators

  • Study Chair: Michel Adamina, Prof. Dr. med., Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
  • Principal Investigator: Anas Taha, Dr. med., None currently
  • Principal Investigator: Thomas Steffen, Cantonal Hospital of St. Gallen
  • Principal Investigator: Stephanie Taha-Mehlitz, Dr. med., Department of Visceral Surgery, Clarunis, University Hospital Basel, Basel, Switzerland
  • Principal Investigator: Frédéric Ris, Prof. Dr. med., Department of Surgery, Hôpitaux Universitaires de Genève

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Michel Adamina, MD, Chefarzt, Kantonsspital Winterthur KSW
ClinicalTrials.gov Identifier:
NCT04985981
Other Study ID Numbers:
  • PANIC
First Posted:
Aug 2, 2021
Last Update Posted:
Dec 1, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Michel Adamina, MD, Chefarzt, Kantonsspital Winterthur KSW
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2021